Pathophysiological significance of T-type Ca2+ channels: Role of T-type Ca2+ channels in renal microcirculation

Koichi Hayashi, Shu Wakino, Koichiro Honma, Naoki Sugano, Takao Saruta

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Since conventional Ca2+ antagonists, with predominant blockade of L-type voltage-dependent Ca2+ channels, elicit preferential dilation of afferent arterioles, they might ostensibly aggravate glomerular hypertension. Recently, novel Ca2+ antagonists, with inhibitory action on L-/T-type Ca2+ channels, have been reported to dilate both afferent and efferent arterioles. The present review attempted to characterize the renal action of these Ca2+ antagonists and evaluated the consequences following the treatment with these agents. In contrast to conventional Ca2+ antagonists (e.g., nifedipine), novel antagonists (e.g., benidipine, efonidipine) potently dilated afferent and efferent arterioles; their action on efferent arterioles appeared to be mediated by the T-type Ca2+ channel blockade, probably through the inhibition of the intracellular Ca2+ release. The comparison of the anti-proteinuric action in subtotally nephrectomized rats showed that efonidipine exerted more prominent action than nifedipine. Furthermore, Ca2+ antagonists with T-type Ca2+ inhibitory action inhibited renin/aldosterone release and proinflammatory process. Finally, patients with chronic renal disease given a 48-week efonidipine treatment showed reduced proteinuria, and this effect was seen even when mean arterial blood pressure failed to become less than 100 mmHg. Collectively, T-type Ca2+ channel blockade provides beneficial action in renal injury. Various mechanisms serve to protect against renal injury, including systemic/glomerular hemodynamic action and non-hemodynamic mechanisms.

Original languageEnglish
Pages (from-to)221-227
Number of pages7
JournalJournal of Pharmacological Sciences
Volume99
Issue number3
DOIs
Publication statusPublished - 2005

Fingerprint

Arterioles
Microcirculation
Kidney
Nifedipine
Arterial Pressure
Wounds and Injuries
Aldosterone
Chronic Renal Insufficiency
Proteinuria
Renin
Dilatation
Hemodynamics
Hypertension
Therapeutics
efonidipine

Keywords

  • Efonidipine
  • Mibefradil
  • Renal disease
  • Renal microcirculation
  • Voltage-dependent Ca channel

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pathophysiological significance of T-type Ca2+ channels : Role of T-type Ca2+ channels in renal microcirculation. / Hayashi, Koichi; Wakino, Shu; Honma, Koichiro; Sugano, Naoki; Saruta, Takao.

In: Journal of Pharmacological Sciences, Vol. 99, No. 3, 2005, p. 221-227.

Research output: Contribution to journalArticle

@article{8d89caa1c781422ea8437cbe44f60dd5,
title = "Pathophysiological significance of T-type Ca2+ channels: Role of T-type Ca2+ channels in renal microcirculation",
abstract = "Since conventional Ca2+ antagonists, with predominant blockade of L-type voltage-dependent Ca2+ channels, elicit preferential dilation of afferent arterioles, they might ostensibly aggravate glomerular hypertension. Recently, novel Ca2+ antagonists, with inhibitory action on L-/T-type Ca2+ channels, have been reported to dilate both afferent and efferent arterioles. The present review attempted to characterize the renal action of these Ca2+ antagonists and evaluated the consequences following the treatment with these agents. In contrast to conventional Ca2+ antagonists (e.g., nifedipine), novel antagonists (e.g., benidipine, efonidipine) potently dilated afferent and efferent arterioles; their action on efferent arterioles appeared to be mediated by the T-type Ca2+ channel blockade, probably through the inhibition of the intracellular Ca2+ release. The comparison of the anti-proteinuric action in subtotally nephrectomized rats showed that efonidipine exerted more prominent action than nifedipine. Furthermore, Ca2+ antagonists with T-type Ca2+ inhibitory action inhibited renin/aldosterone release and proinflammatory process. Finally, patients with chronic renal disease given a 48-week efonidipine treatment showed reduced proteinuria, and this effect was seen even when mean arterial blood pressure failed to become less than 100 mmHg. Collectively, T-type Ca2+ channel blockade provides beneficial action in renal injury. Various mechanisms serve to protect against renal injury, including systemic/glomerular hemodynamic action and non-hemodynamic mechanisms.",
keywords = "Efonidipine, Mibefradil, Renal disease, Renal microcirculation, Voltage-dependent Ca channel",
author = "Koichi Hayashi and Shu Wakino and Koichiro Honma and Naoki Sugano and Takao Saruta",
year = "2005",
doi = "10.1254/jphs.FMJ05002X6",
language = "English",
volume = "99",
pages = "221--227",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8613",
publisher = "Japanese Pharmacological Society",
number = "3",

}

TY - JOUR

T1 - Pathophysiological significance of T-type Ca2+ channels

T2 - Role of T-type Ca2+ channels in renal microcirculation

AU - Hayashi, Koichi

AU - Wakino, Shu

AU - Honma, Koichiro

AU - Sugano, Naoki

AU - Saruta, Takao

PY - 2005

Y1 - 2005

N2 - Since conventional Ca2+ antagonists, with predominant blockade of L-type voltage-dependent Ca2+ channels, elicit preferential dilation of afferent arterioles, they might ostensibly aggravate glomerular hypertension. Recently, novel Ca2+ antagonists, with inhibitory action on L-/T-type Ca2+ channels, have been reported to dilate both afferent and efferent arterioles. The present review attempted to characterize the renal action of these Ca2+ antagonists and evaluated the consequences following the treatment with these agents. In contrast to conventional Ca2+ antagonists (e.g., nifedipine), novel antagonists (e.g., benidipine, efonidipine) potently dilated afferent and efferent arterioles; their action on efferent arterioles appeared to be mediated by the T-type Ca2+ channel blockade, probably through the inhibition of the intracellular Ca2+ release. The comparison of the anti-proteinuric action in subtotally nephrectomized rats showed that efonidipine exerted more prominent action than nifedipine. Furthermore, Ca2+ antagonists with T-type Ca2+ inhibitory action inhibited renin/aldosterone release and proinflammatory process. Finally, patients with chronic renal disease given a 48-week efonidipine treatment showed reduced proteinuria, and this effect was seen even when mean arterial blood pressure failed to become less than 100 mmHg. Collectively, T-type Ca2+ channel blockade provides beneficial action in renal injury. Various mechanisms serve to protect against renal injury, including systemic/glomerular hemodynamic action and non-hemodynamic mechanisms.

AB - Since conventional Ca2+ antagonists, with predominant blockade of L-type voltage-dependent Ca2+ channels, elicit preferential dilation of afferent arterioles, they might ostensibly aggravate glomerular hypertension. Recently, novel Ca2+ antagonists, with inhibitory action on L-/T-type Ca2+ channels, have been reported to dilate both afferent and efferent arterioles. The present review attempted to characterize the renal action of these Ca2+ antagonists and evaluated the consequences following the treatment with these agents. In contrast to conventional Ca2+ antagonists (e.g., nifedipine), novel antagonists (e.g., benidipine, efonidipine) potently dilated afferent and efferent arterioles; their action on efferent arterioles appeared to be mediated by the T-type Ca2+ channel blockade, probably through the inhibition of the intracellular Ca2+ release. The comparison of the anti-proteinuric action in subtotally nephrectomized rats showed that efonidipine exerted more prominent action than nifedipine. Furthermore, Ca2+ antagonists with T-type Ca2+ inhibitory action inhibited renin/aldosterone release and proinflammatory process. Finally, patients with chronic renal disease given a 48-week efonidipine treatment showed reduced proteinuria, and this effect was seen even when mean arterial blood pressure failed to become less than 100 mmHg. Collectively, T-type Ca2+ channel blockade provides beneficial action in renal injury. Various mechanisms serve to protect against renal injury, including systemic/glomerular hemodynamic action and non-hemodynamic mechanisms.

KW - Efonidipine

KW - Mibefradil

KW - Renal disease

KW - Renal microcirculation

KW - Voltage-dependent Ca channel

UR - http://www.scopus.com/inward/record.url?scp=28044448714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044448714&partnerID=8YFLogxK

U2 - 10.1254/jphs.FMJ05002X6

DO - 10.1254/jphs.FMJ05002X6

M3 - Article

C2 - 16293936

AN - SCOPUS:28044448714

VL - 99

SP - 221

EP - 227

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8613

IS - 3

ER -